Two-Thirds Of The Population Have COVID-19 Antibodies Says Study

About two-thirds of the general population have COVID-19 antibodies and 67.6% of India’s population were exposed to the disease, the fourth serosurvey conducted by ICMR during the June-July 2021 period found.

Two-Thirds Of The Population Have COVID-19 Antibodies Says Study

The fourth serosurvey was conducted in the same 70 districts; 21 States as the previous three rounds. About 28,975 individuals were enrolled. The breakdown of this group in terms of age is as follows:

  • Ages 6-9 years: 2,892 (10%)
  • Ages 10-17 years: 5,799 (20%)
  • Greater than 18 years: 20,284 (70%)

According to this survey, about two-thirds of the general population have COVID-19 antibodies and 67.6% of India’s population were exposed to the disease.

As reported by GreatGameIndia earlier, results of a study published in the International Journal of Clinical Practuce found that there is enough literature available to determine that COVID-19 vaccines increases the risk of more severe diseases and that recipients should be made aware of all the risks before being vaccinated.

The scientists concluded that vaccines may worsen COVID-19 disease via antibody-dependent enhancement (ADE) and that the risks are kept secret in clinical trial protocols and consent forms.

Nobel Prize winner French Virologist Prof. Luc Montagnier in an interview made a startling claim that the COVID-19 vaccines itself are creating variants. He said that epidemiologists know but are “silent” about the phenomenon, known as “Antibody-Dependent Enhancement” (ADE).

3 Responses

  1. 67.6% have antibodies which is much more than what one would get with the vaccine generating spike protein in your body.

  2. 67.6% is referring to the # of people in the population , not the immunity of an individual. Vaccine still seems like a bad idea. You have to trust the system to take it. And I don’t trust them right now. Too much of their behavior has felt intuitively bizarre lately. At times overtly inconsistent.

Leave a Reply